NEW YORK (TheStreet) -- CHANGE IN RATINGS
rated new Hold at Jefferies. Coverage of BMY was started with a Hold rating. $27 price target. Stock is already priced for perfect execution.
upgraded at BofA/Merrill to Neutral from Underperform on more balance risk. Price target raised by a dollar to $13.
rated new Outperform at Baird. $48 price target. See significant upside potential ahead of the May 1 PDUFA date.
rated new Buy at Deutsche. $41 price target. Stock trades at a 40% discount to the market.
initiated at Barclays with an Overweight rating and $5 price target. Spending on test equipment should be higher than expected in 2011. 2010 and 2011 EPS estimates set at 12 and 35 cents, respectively.
downgraded at BofA/Merrill to Neutral from Buy on new long term gas price assumptions. Price target set at $24.
upgraded at Deutsche from Hold to Buy. $38 price target. Valuation call, with dividends up and higher moly prices.
STOCK COMMENTS / EPS CHANGES
numbers boosted at Goldman. Shares of ARO now seen reaching $26. Estimates also upped, given the company's higher gross margin. Neutral rating.
numbers increased at Goldman. BKE estimates were raised through 2011. Company posted higher sales, but fashion trends could be working again future demand. Sell rating and new $25 price target.
numbers boosted at Goldman. Shares of CMP now seen reaching $94. Estimates also raised, as the company is seeing better pricing and cost trends. Neutral rating.
numbers increased at Kaufman. Shares of CY now seen reaching $15. Estimates also boosted as the company can grow market share in multiple areas. Buy rating.
estimates, target raised at Oppenheimer. Shares of GOOG now seen reaching $715. Estimates also increased, because of higher expected volume and sustained pricing. Outperform rating.
cut from Conviction Sell list at Goldman Sachs. Macro environment has improved. $21 price target.
estimates, target upped at Goldman. Shares of LULU now seen reaching $40. Estimates also increased, as sales trends are accelerating. Buy rating.
numbers increased at Goldman through 2011. Dairy costs have pulled back and M&A can fuel future growth. Buy rating and new $57 price target.
estimates boosted at Goldman through 2012. PC product cycle will drive growth. Buy rating and $38 price target.
target raised at UBS to $72. Company is seeing lower churn and should benefit from competitors closing stores. Neutral rating.
price target cut at Citigroup by a dollar to $22. Maintain Buy rating.
numbers upped at Goldman. Shares of NSM now seen reaching $13. Estimates also raised, because of a sales recovery and lower operating expenses. Sell rating.
Research in Motion
cut from Focus List at Kaufman. Stock is up 21% since Feb. 1 and could be subject to profit-taking.
estimates raised at Morgan Stanley through 2011. Company is seeing better profit margins, aided by lower interest costs. Equal-weight rating.
estimates raised at Goldman through 2012. Company is growing sales through multiple channels. Buy rating and $103 price target.
estimates tweaked at Barclays. XOM 2011 EPS estimate lowered 5 cents to $7.35, 2010 maintained at $5.95. Maintain Overweight rating and $92 price target.
estimates upped at Morgan Stanley through 2012. Equal-weight rating and $80 price target.
This article was written by a staff member of TheStreet.com.